Detalhe da pesquisa
1.
Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.
J Nanobiotechnology
; 20(1): 436, 2022 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195911